(Total Views: 564)
Posted On: 11/22/2025 9:15:19 AM
Post# of 158792
Re: KenChowder #158605
I also noticed this the other day in the Sept shareholder letter
"Obtain biopsy tissue from patients with disease progression enrolling in the rollover protocol to correlate PD-L1 levels and changes in the tumor microenvironment on tumor tissue with PD-L1 expression on concurrently drawn CTCs"
"Obtain biopsy tissue from patients with disease progression enrolling in the rollover protocol to correlate PD-L1 levels and changes in the tumor microenvironment on tumor tissue with PD-L1 expression on concurrently drawn CTCs"